1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,196 | 0,220 | 07:05 | |
| 0,200 | 0,220 | 07:05 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | BRII-B (02137): GRANT OF SHARE OPTIONS | 1 | HKEx | ||
| Di | BRII-B (02137): GRANT OF SHARE OPTIONS AND RESTRICTED SHARE UNITS | 1 | HKEx | ||
| 27.10. | BRII-B (02137): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 18.09. | BRII-B (02137): NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED SHAREHOLDERS | - | HKEx | ||
| 18.09. | BRII-B (02137): NOTIFICATION LETTER AND CHANGE REQUEST FORM FOR REGISTERED SHAREHOLDERS | - | HKEx | ||
| 18.09. | BRII-B (02137): 2025 INTERIM REPORT | - | HKEx | ||
| 17.09. | BRII-B (02137): NEXT DAY DISCLOSURE RETURN | 2 | HKEx | ||
| BRII BIOSCIENCES Aktie jetzt für 0€ handeln | |||||
| 27.08. | BRII-B (02137): SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ANNUAL REPORT FOR THE YEAR ENDED DECEMBER 31, 2024 | 3 | HKEx | ||
| 25.08. | Leerink Partners raises Brii Biosciences stock price target to HK$2.00 on HBV data | 2 | Investing.com | ||
| 25.08. | BRII-B (02137): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 21.08. | Brii Biosciences reports 1H results | 1 | Seeking Alpha | ||
| 21.08. | Brii Biosciences Limited: Brii Biosciences Provides Corporate Updates and Reports 2025 Interim Financial Results | 80 | PR Newswire | Multiple Ongoing Phase 2b Studies Advancing HBV Functional Cure Strategy
Greater China Partnership with Joincare to Accelerate Development of Critical Care Antibiotic... ► Artikel lesen | |
| 21.08. | BRII-B (02137): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025 | 1 | HKEx | ||
| 11.08. | BRII-B (02137): DATE OF BOARD MEETING | 1 | HKEx | ||
| 04.07. | Brii Biosciences and Joincare sign licence agreement for BRII-693 | 1 | Pharmaceutical Technology | ||
| 04.07. | BRII-B (02137): VOLUNTARY ANNOUNCEMENT LICENSE AGREEMENT WITH JOINCARE | 2 | HKEx | ||
| 03.06. | BRII-B (02137): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | - | HKEx | ||
| 03.06. | BRII-B (02137): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 3, 2025 AND CHANGE IN COMPOSITION OF THE NOMINATION COMMITTEE | 1 | HKEx | ||
| 08.05. | BRII-B (02137): VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE | 1 | HKEx | ||
| 30.03. | Brii Biosciences Limited: Brii Bio Unveils New Data from Its Ongoing Phase 2 ENSURE Study at APASL 2025, Showcasing BRII-179's Unique Potential to Prime and Boost Higher HBsAg Loss Through Target Patient Identification | 91 | PR Newswire | Preliminary data from Cohort 4 of the ENSURE study supports a novel enrichment strategy to utilize BRII-179 to identify patients who are immune responders and... ► Artikel lesen |
1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIOGEN | 134,45 | +0,37 % | Ihre wichtigsten Termine: Apple, Mastercard, Eli Lilly, Biogen, VW, Wacker Chemie und Lufthansa im Fokus! | © Foto: Jonathan Brady/PA Wire/dpa +++ dpa-Bildfunk Gut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine... ► Artikel lesen | |
| ILLUMINA | 107,18 | -0,24 % | Illumina, Inc.: Illumina Reports Financial Results for Third Quarter of Fiscal Year 2025 | Revenue of $1.08 billion for Q3 2025, flat compared to Q3 2024 on both a reported and constant currency basis
GAAP operating margin of 21.0% and non-GAAP operating... ► Artikel lesen | |
| NANOREPRO | 1,685 | -0,88 % | EQS-News: NanoRepro AG: Halbjahreszahlen 2025 - NanoRepro setzt Wachstumskurs fort | EQS-News: NanoRepro AG
/ Schlagwort(e): Halbjahresbericht
NanoRepro AG: Halbjahreszahlen 2025 - NanoRepro setzt Wachstumskurs fort
31.10.2025 / 12:00 CET/CEST
Für den... ► Artikel lesen | |
| BRAIN BIOTECH | 2,170 | -1,36 % | EQS-PVR: BRAIN Biotech AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: BRAIN Biotech AG
BRAIN Biotech AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
20.10.2025 / 15:38 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| BIONXT SOLUTIONS | 0,504 | -0,79 % | Besser als BioNTec, Evotec und Co.? BioNxt Solutions steht vor Meilensteinen und prüft KI-Übernahme - Aktie im Aufwärtstrend | Eine spannende Alternative zu Evotec, BioNTech und Co. ist BioNxt Solutions. Das kanadisch-deutsche Unternehmen unterscheidet sich mit seinem Geschäftsmodell erfrischend von dem klassischer Biotechs... ► Artikel lesen | |
| INFLARX | 1,251 | -0,95 % | InflaRx N.V.: InflaRx Regains Compliance with Nasdaq Minimum Bid Price Requirement | JENA, Germany, Sept. 12, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system (the "Company")... ► Artikel lesen | |
| SIRONA BIOCHEM | 0,037 | -100,00 % | Sirona Biochem Corp.: Sirona Biochem Update to Shareholders on Financial Status and Operations | VANCOUVER, British Columbia, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) ("Sirona") wishes to provide shareholders with a critical update on the company's financial... ► Artikel lesen | |
| DEFENCE THERAPEUTICS | 0,460 | -4,76 % | Defence Therapeutics Inc.: Defence to Present New Scientific Data on Its ADC-Enhancing Accum Technology at the World ADC Conference in San Diego, USA, November 4-5, 2025 | Montreal, Quebec--(Newsfile Corp. - October 23, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company specialized in drug... ► Artikel lesen | |
| TREVENA | 2,280 | -40,00 % | Hollywood Changemaker Oliver Trevena Joins Little Kitchen Academy as Investor | LOS ANGELES, CA / ACCESS Newswire / August 21, 2025 / Little Kitchen Academy (LKA), the premier Montessori-inspired cooking academy for children and teens ages 3-18, is proud to announce that Oliver... ► Artikel lesen | |
| BURCON NUTRASCIENCE | 1,570 | -4,27 % | Burcon NutraScience Corporation: Burcon Pea and Sunflower Proteins Outperform in Plant-based Cheese Study | Vancouver, British Columbia--(Newsfile Corp. - October 20, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) (the "Burcon" or the "Company"), a global technology leader in plant-based... ► Artikel lesen | |
| TME PHARMA | 0,094 | 0,00 % | TME Pharma N.V.: TME Pharma Announces Date of Publication of Half Year Results and CEO Share Purchase | Regulatory News:
TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company specializing in the development of novel therapies for cancer and eye diseases, announces... ► Artikel lesen | |
| CYTODYN | 0,210 | +5,00 % | CytoDyn Inc.: September 2025 Letter to Shareholders | VANCOUVER, Washington, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Dear Shareholders, As this pivotal year continues to take shape for CytoDyn Inc. ("CytoDyn" or the "Company"), I am pleased to share the... ► Artikel lesen | |
| IMMUNIC | 0,680 | +0,30 % | EQS-News: Immunic AG: Immunic to Participate in Industry and Investor Conferences in November | Issuer: Immunic AG
/ Key word(s): Conference
Immunic to Participate in Industry and Investor Conferences in November
29.10.2025 / 11:30 CET/CEST
The issuer is solely... ► Artikel lesen | |
| PHIO PHARMACEUTICALS | 2,020 | -0,98 % | Phio Pharmaceuticals Corp.: Phio Pharmaceuticals Announces Appointment of Mr. David H. Deming to the Position of Lead Independent Director | King of Prussia, Pennsylvania--(Newsfile Corp. - October 31, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its... ► Artikel lesen | |
| IOVANCE BIOTHERAPEUTICS | 1,675 | -1,66 % | Iovance Biotherapeutics, Inc.: Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) | SAN CARLOS, Calif., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the "Company"), a biotechnology company focused on innovating, developing, and delivering... ► Artikel lesen |
BRII BIOSCIENCES LTD gehört der Branche Biotechnologie an. Mit einer aktuellen Kursveränderung von +0,002 (+1,04 %) liegt der Kurs bei 0,195 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BRII BIOSCIENCES LTD finden Sie auf Wallstreet Online.